Toxoplasma gondii in schizophrenia;Toxoplasma gondii u schizofrenie

Psychiatrie

Volumn 10, Issue 2, 2006, Pages 81-87

  Holub, David ^a,b   Motlová, Lucie ^c   Rodriguez, Mabel ^c   Preiss, Marek ^c   Čermák, Jan ^c   Libiger, Jan ^b  

^a Tonna Hospital   (United Kingdom)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Cognitive dysfunctions; First episode schizophrenia; Psychopathology; Schizophrenia; Toxoplasma gondii

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AUTOIMMUNE DISEASE; BEHAVIOR CHANGE; BIPOLAR DISORDER; BRAIN DEVELOPMENT; CAT; COGNITION; COGNITIVE DEFECT; CYTOKINE RELEASE; HUMAN; INTRAUTERINE INFECTION; MOLECULAR GENETICS; NEUROLOGIC EXAMINATION; NEUROTRANSMISSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRENATAL EXPOSURE; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 33745812092     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Arnott MA, Cassella JP, Aitken PP, Hay J. Social interactions of mice with congenital Toxoplasma infection. Ann Tropic Med Parasitol 1990;84:149-56.
2. Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in First-Episode Schizophrenia and Antibodies to Toxoplasma gondii. Psychopath 2005;38:87-90.
3. Berdoy M, Webster JP, Macdonald DW. Parasite-altered behaviour: Is the effect of Toxoplasma gondii on Rattus norvegicus specific? Parasitology 1995;111:403-9.
4. Boronow J, Dickerson F, Stallings C, Lee B, Origoni A, Yolken R. HSV-1, CMV and Toxoplasma serology predict cognitive deficits in schizophrenia [abstract]. Schizophr Res 2002;53:85.
5. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas V, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005;162:767-773.
6. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas V, Susser ES. Serologic Evidence of Prenatal Exposure to Toxoplasmosis in the Etiology of Schizophrenia, Abstracts GA: International Savannah Congress on Schizophrenia Research, 2005.
7. Buffolano W, Gilbert RE, Holland FJ, Fratta D, Palumbo F, Hiilesmaa V, Koskiniemi M. Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol Infect 1996; 116: 347-51.
8. Buka SL, Yolken RH, Torrey EF, Klebanoff MA, Tsuang MT. Viruses, fetal hypoxia and subsequent schizophrenia. A direct test of infectious agents using prenatal sera [abstract]. Schizophr Res 1999;36:38.
9. Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res 2003;60:65-69.
10. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 2000;321:142-47.
11. Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001;55:585-595.
12. Creuzet C, Robert F, Roisin MP, Van Tan H, Benes C, Dupouy-Camet J, et al. Neurons in primary cultures are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res 1998; 84: 25-30.
13. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-33.
14. Daffos F, Forestier F, Capella-Pavlovsky M, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988; 318: 271-75.
15. Desmonts G, Couvreur J. Congenital toxoplasmosis. A prospective study of 378 pregnancies. N Eng J Med 1974;290:1110-16.
16. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii Tachyzoites, Bradyzoites and Sporozoites and Biology and Development of Tissue Cysts. Clin Microbiol Rev Apr 1998;267-299.
17. Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 1994;41:122-126.
18. Flegr J, Zitková S, Kodym P, Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 1996;113:49-54.
19. Flegr J, Havlicek J. Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitol.(Praha.) 1999;46:22-28.
20. Flegr J, Hrdá Š, Havlíček J. Rozdíly v osobnostním profilu biologu̇ nakažených a nenakažených T. gondii. Remedia Klin Mikrobiol 1999.
21. Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biological Psychology 2000;53:57-68.
22. Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study, Bmc Infectious Diseases 2002;2:1-6.
23. Flegr J, Preiss M, Klose J, Havlíček J, Vitáková M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biological Psychology 2003;63:253-268
24. Gu H, Yolken RH, Phillips M, Yang F, Bilder RM, Gilmore JH, Lieberman JA. Evidence of Toxoplasma gondii infection in recent-onset schizophrenia [abstract]. Schizophr Res 2001;49:53.
25. Guerina N, Hsu H-W, Meissner H, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994;330:1858-63.
26. Hanzlíček, L. Podíl toxoplazmózy v psychiatrii. Doktorská dizertační práce. Praha, VÚPs, 1962, 15.
27. Havlíček J, Gasova Z, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent ,asymptomatic' toxoplasmosis, Parasitology 2001;122:515-520.
28. Havlík J et al. Infektologie, učebnice pro lékařské fakulty. Avicenum 1990, 345-7.
29. Hay J, Hutchison WM, Aitken PP. Congenital Toxoplasma infection and response to novelty in mice. Ann Tropic Med Parasitol 1983;77:437-39.
30. Hay J, Aitken PP, Graham DI. Toxoplasma infection and response to novelty in mice. Z Parasitenkd 1984;70:575-88.
31. Hay J, Aitken PP, Arnott MA. The influence of Toxoplasma infection on the spontaneous running activity of mice. Z Parasitenkd 1985;71:459-62.
32. Hinze-Selch, Pollmacher T. In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research. Brain Behav Immun 2001;15:282-318.
33. Höschl C, Balon R. Výsledky psychiatrického vyšetřování nemocných toxoplasmosou. Čas Lék čes 1980;119:366-68.
34. Höschl, C., Karásková, E.: Infekční původ schizofrenie? Čas. Lék. Čes., 124, 1985, s.865-868.
35. Hrda S, Votypka J, Kodym P, Flegr J. Transient nature of Toxoplasma gondii-induced behavioral changes in mice, Journal of Parasitology 2000;86:657-663.
36. Hutchison WM, Bradley M, Cheyne WM, Wells BWP, Hay J. Behavioural abnormalities in Toxoplasma-infected mice. Ann Tropic Med Parasitol 1980;74:337-45.
37. Jenum PA, Stray-Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women J Clin Microbiol 1998;36:2900-06.
38. Jíra J. Imunodiagnostika a epidemiologie toxoplasmosy. Praha; Academia, 1983:262.
39. Jírovec O, Jíra J, Fuchs V, Peter R. Studien mit dem Toxoplasmintest. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene (1. orig) 1957;169:129-59.
40. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003;62:237-44.
41. Karlsson H, Bachmann S, Schröder J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Natl Acad Sci USA 2001;98:4634-4639.
42. Kirch DG. Infection and autoimmunity as etiologic factors in schizophrenia: A review and reappraisal. Schizophr Bull 1993;19:355-70.
43. Kolář J, Švarzberger F, Anton J, Jíra J, Jírovec O, Bozděch V. Vztah mezi intrakraniálními kalcifikacemi a diagnostickými testy na toxoplazmózu. Čs Radiol, 23, 1969;4:145-153.
44. Krejsek J, Kopecký O. Klinická imunologie. Nucleus Hradec Králové, 2004;534-540.
45. Lebech M, Larsen SO, Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Infect Dis 1993;25:751-56.
46. Lebech M, Andersen O, Christensen NC, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-37.
47. Lappalainen M, Koskela P, Hedman K, Teramo K, Ammala P, Hiilesmaa V, Koskiniemi M. Incidence of Primary Toxoplasma Infections During Pregnancy in Southern Finland - A Prospective Cohort Study. Scand J Infect Dis 1992;24:97-104.
48. Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004;254:4-8.
49. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-76.
50. Mortensen PB, Yolken RH, Lindum B, Sorensen T, Houeaard D, Pedersen BN. Toxoplasmosis and Other Early Infections in Relation to Schizophrenia Risk. Abstract No. 115955. 2005 Abstract Viewer. Savannah, GA: International Congress on Schizophrenia Research.
51. Motlová L, Koukolík F. Schizofrenie: Neurobiologie, klinika, terapie. Galen, 2005. ISBN 80-7262-277-3.
52. Novotná M, Hanusova J, Klose J, Preiss, Havlicek J, Roubalová K, Flegr J. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infectious Diseases 2005, 5:54. http://www.biomedcentral.com/1471-2334/5/54/ prepub.
53. Petrovický O, Vojtěchovský M. Klinický obraz získané toxoplasmosy s neurologického a psychiatrického hlediska. Čas Lék Čes 1955;94:1-10.
54. Qiuying L, Xiaonian L, Li L, et al. [The control study of schizophrenia and affective disorders and Toxoplasma infections.] Acta Academiae Medicinae Hubei 1999;20:223-5.
55. Rentakallio P, Jones P, Moring J, Von Wende L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 1997;26:837-43.
56. Skallová A, Novotná M, Kolbeková P, Gašová Z, Veselý V, Sechovská M, Flegr J. Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuroendocrinology Letters, 2006; 25: 480-486.
57. Song C, Leonard BE. Základy psychoneuroimunologie. JOHN WILEY AND SONS, LTD, české vydání, vydala Česká neuropsychofarmakologická společnost a firma Sanofi-Synthelabo, Česká republika 2003;98-111,127-129.
58. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull 1995; 21:167-71.
59. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res 2000;46:17-23.
60. Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia, Emerging Infectious Diseases 2003;9:1375-1380
61. Torrey EF, Yolken RH. Toxoplasmosis and Schizophrenia: Is the Cat in the Hat? Abstract No. 113648. 2005 Abstract Viewer. Savannah, GA: International Congress on Schizophrenia Research.
62. Vojtěchovská M, Vojtěchovský M, Petrů M. Některé parasitologické problémy u duševně nemocných. Čas Lék Čes 1956;95:559-66.
63. Webster JP. The effect of Toxoplasma gondii and other parasites on activity levels in wild and hybrid Rattus norvegicus. Parasitology 1994;109:583-89.
64. Webster JP. Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microbes and Infection, 3,2001,1037-1045.
65. Yolken RH, Bachmann S, Rouslanova I, Lillehoj E, Ford G, Torrey EF, Schroeder J. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases 2001;32:842-844.